Your browser doesn't support javascript.
loading
In Vitro Characterization of a Novel Type of Radiopaque Doxorubicin-Loaded Microsphere.
Pan, Feng; Schneider, Daniel; Ryschich, Eduard; Qian, Baifeng; Vollherbst, Dominik F; Möhlenbruch, Markus A; Jugold, Manfred; Eichwald, Viktoria; Stenzel, Philipp; Pereira, Philippe L; Richter, Götz M; Kauczor, Hans U; Sommer, Christof M; Do, Thuy D.
Afiliación
  • Pan F; Clinic of Diagnostic and Interventional Radiology, Heidelberg University Hospital, INF 110, 69120, Heidelberg, Germany.
  • Schneider D; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ryschich E; Clinic of Diagnostic and Interventional Radiology, Heidelberg University Hospital, INF 110, 69120, Heidelberg, Germany.
  • Qian B; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Vollherbst DF; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Möhlenbruch MA; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jugold M; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Eichwald V; Core Facility Small Animal Imaging, German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Stenzel P; Core Facility Small Animal Imaging, German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Pereira PL; Institute of Pathology, Mainz University Hospital, Mainz, Germany.
  • Richter GM; Clinic for Radiology, Minimally-Invasive Therapies and Nuclearmedicine, SLK-Kliniken GmbH, Heilbronn, Germany.
  • Kauczor HU; Clinic of Diagnostic and Interventional Radiology, Klinikum Stuttgart, Kriegsbergstrasse 60, 70174, Stuttgart, Germany.
  • Sommer CM; Clinic of Diagnostic and Interventional Radiology, Heidelberg University Hospital, INF 110, 69120, Heidelberg, Germany.
  • Do TD; Clinic of Diagnostic and Interventional Radiology, Heidelberg University Hospital, INF 110, 69120, Heidelberg, Germany. christof.sommer@med.uni-heidelberg.de.
Cardiovasc Intervent Radiol ; 43(4): 636-647, 2020 Apr.
Article en En | MEDLINE | ID: mdl-31965224
PURPOSE: To evaluate and compare the material characteristics of a novel type of radiopaque doxorubicin-loaded microsphere (V-100) with radiopaque and non-radiopaque doxorubicin-loaded microspheres. MATERIALS AND METHODS: The prototype V-100 featuring inherent radiopacity and three available commercial controls (DC-Bead-LUMI™-70-150, Embozene-Tandem™-100 and DC-Bead™-M1) were analyzed before and after doxorubicin loading (37.5 mg doxorubicin/1 ml microspheres) in suspension with aqua and/or aqua/iodixanol-320. Study goals included inherent radiopacity [e.g., using conventional computed tomography (CT)], doxorubicin loading efficacy, morphology using light and fluorescence microscopy, size distribution using laser diffraction/light scattering, time-in-suspension, rheological properties using rheometer analysis, and microsphere stability observed over a period of 5 days after doxorubicin loading. RESULTS: V-100 showed good inherent radiopacity without adverse imaging artifacts. Under conventional CT, the quantitative radiopacity was as follows: 480.4 ± 2.9HU for V-100, 2432.7 ± 3.2HU for DC-Bead-LUMI™-70-150, 118.1 ± 3.0HU for Embozene-Tandem™-100, and 19.8 ± 1.5HU for DC-Bead™-M1. All of the types of microspheres showed a similar loading efficiency (> 98%) after 24 h; however, there were slower doxorubicin loading velocities for the radiopaque microspheres. The doxorubicin-loaded V-100 and Embozene-Tandem™-100 showed typical narrow-sized distributions. In aqua/iodixanol-320 suspension, doxorubicin-loaded V-100 showed the best suspension features and ideal deformability and elasticity characteristics. Similar to other microspheres, doxorubicin-loaded V-100 was very stable and storable for at least 5 days. CONCLUSION: V-100 is a promising novel type of radiopaque doxorubicin-loaded microsphere. Compared with the controls, V-100 shows good inherent radiopacity without adverse imaging artifacts and with comparable doxorubicin loading efficacy. Further advantages of V-100 include narrow-sized distribution and excellent suspension, rheology, and stability features.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Doxorrubicina / Sistemas de Liberación de Medicamentos / Microesferas / Antibióticos Antineoplásicos Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Doxorrubicina / Sistemas de Liberación de Medicamentos / Microesferas / Antibióticos Antineoplásicos Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2020 Tipo del documento: Article País de afiliación: Alemania